hoe 33342 has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Felekkis, K; Flies, A; Lerner, A; Moon, EY; Sherr, DH; Tiwari, S | 1 |
Canitrot, Y; Lahmy, S; Laurent, G; Lautier, D; Salmon, JM | 1 |
2 other study(ies) available for hoe 33342 and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Apoptosis; B-Lymphocytes; Benzimidazoles; Colforsin; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Inhibitors; Fluorescent Dyes; Guanine Nucleotide Exchange Factors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Monocytes; rap1 GTP-Binding Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; T-Lymphocytes | 2004 |
Staining with Hoechst 33342 and rhodamine 123: an attempt to detect multidrug resistant phenotype cells in leukemia.
Topics: Adult; Aged; Antigens, CD; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Carrier Proteins; Drug Resistance; Female; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Membrane Glycoproteins; Middle Aged; Phenotype; Rhodamine 123; Rhodamines; Verapamil | 1993 |